Skip to main content

Table 1 Characteristics of infected patients with or without sepsis defined by Sepsis-3 or eSOFA criteria

From: External validity of Adult Sepsis Event’s simplified eSOFA criteria: a retrospective analysis of patients with confirmed infection in China

Characteristic

eSOFA (−)

n = 1143

eSOFA (+)

n = 573

Sepsis-3 (−)

n = 781

Sepsis-3 (+)

n = 935

Median age (IQR)

79 (62–84)

82 (75–87)**

78 (57–84)

81 (74–86)

Gender, n (%)

    

 Male

642 (56.2)

346 (60.4)

414 (53.0)

574 (61.4)

BMI, kg/m2, median (IQR)

23 (20–26)

23 (20–26)

24 (21–26)

23 (20–26)

Bedridden, n (%)

580 (50.7)

310 (54.1)**

388 (49.7)

502 (53.7)

Type of hospital admission, n (%)

    

 Medical

1047 (91.6)

506 (88.3)*

691 (88.5)

862 (92.2)

 Elective surgery

85 (7.4)

43 (7.5)

75 (9.6)

53 (5.7)

 Emergency surgery

11 (1.0)

24 (4.2)**

15 (1.9)

20 (2.1)

McCabe and Jackson classification, n (%)

    

 Nonfatal

814 (71.2)

394 (68.8)

524 (67.1)

684 (73.2)

 Ultimately fatal

169 (14.8)

120 (20.9)**

112 (14.3)

177 (18.9)

 Rapidly fatal

21 (1.8)

24 (4.2)**

22 (2.8)

23 (2.5)

Charlson Comorbidity Index, median (IQR)

1 (1–3)

2 (1–3)**

1 (0–3)

2 (1–3)

Comorbidities (Charlson), n (%)

    

 Cancera

174 (15.2)

131 (22.9)**

133 (17.0)

172 (18.4)

 Congestive heart failure

12 (1.0)

28 (4.9)**

9 (1.2)

31 (3.3)

 Chronic pulmonary disease

237 (20.7)

148 (25.8)*

150 (19.2)

235 (25.1)

 Diabetes

328 (28.7)

126 (22.0)**

206 (26.4)

248 (26.5)

 Liver disease

15 (1.3)

17 (3.0)*

13 (1.7)

19 (2.0)

 Renal disease

46 (4.0)

31 (5.4)

10 (1.3)

67 (7.2)

Chronic organ dysfunction (APACHE II), n (%)

    

 Cardiovascular

11 (1.0)

26 (4.5)**

8 (1.0)

29 (3.1)‡

 Respiratory

37 (3.2)

70 (12.2)**

42 (5.4)

65 (7.0)

 Liver

15 (1.3)

17 (3.0)*

13 (1.7)

19 (2.0)

 Renal

34 (3.0)

21 (3.7)

10 (1.3)

45 (4.8)

 Immunosuppression

94 (8.2)

57 (9.9)

62 (7.9)

89 (9.5)

Site of infection, n (%)

    

 Pneumonia

660 (57.7)

374 (65.3)**

432 (55.3)

602 (64.4)

 Urogenital tract infection

90 (7.9)

11 (1.9)**

68 (8.7)

33 (3.5)

 Intra-abdominal infection

105 (9.2)

72 (12.6)*

81 (10.4)

96 (10.3)

 Skin/soft tissue infection

25 (2.2)

3 (0.5)*

24 (3.1)

4 (0.4)

 Septicemia/bacteremia

18 (1.6)

13 (2.3)

18 (2.3)

13 (1.4)

 Two or more infections

61 (5.3)

66 (11.5)**

55 (7.0)

72 (7.7)

Outcomes

    

 Median hospital LOS (IQR)

17 (9–30)

23 (11–40)*

17 (9–29)

20 (11–38)

 Required ICU admission, n (%)

33 (2.9)

218 (38.1)**

16 (2.0)

235 (25.1)

 Death, n (%)

86 (7.5)

267 (46.6)**

54 (6.9)

299 (32.0)

  1. IQR interquartile range, BMI body mass index, LOS length of stay
  2. *p < 0.05, **p < 0.01, compared with eSOFA (−); p < 0.05, p < 0.01, compared with Sepsis-3 (−)
  3. aCancer includes solid tumor with or without metastases, leukemia, and lymphoma